Previous 10 |
InsiderInsights' Daily Round-Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signi...
Innoviva (NASDAQ: INVA ): Q4 EPS of $2.34 may not be comparable to consensus of $0.65. More news on: Innoviva, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Total net revenue rose 15% to $79.9 million in the fourth quarter of 2018 compared with the fourth quarter of 2017. 1 Income before income taxes increased 25% from the fourth quarter of 2017 to $73.1 million. Innoviva, Inc. (NASDAQ: INVA) (the Company) today reported financial ...
NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Xcel Energy Inc. (NASDAQ:XEL), Empire State Realty Trust, Inc. (NYSE:E...
Gainers: Fortress Biotech (NASDAQ: FBIO ) +41% . MeiraGTx Holdings (NASDAQ: MGTX ) +29% . Eldorado Gold (NYSE: EGO ) +23% . Avon Products (NYSE: AVP ) +22% . Silicom (NASDAQ: SILC ) +20% . Onconova Therapeutics (NASDAQ: ONTX ) +20% . 1-800-FLOWERS.COM (NASDAQ: FLWS ) +19% . Tu...
NEW YORK, Nov. 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Oil States International, Inc. (NYSE:OIS), Brightcove Inc. (NASDAQ:BCOV),...
Innoviva (NASDAQ: INVA ): Q3 GAAP EPS of $0.43 beats by $0.01 . More news on: Innoviva, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Total net revenue rose 26.8% to $61.7 million compared with the third quarter of 2017. Net income attributable to Innoviva stockholders increased 98.1% from the third quarter of 2017 to $47.1 million, or $0.43 per diluted share. The Company made a partial repayment of $110.0 millio...
News, Short Squeeze, Breakout and More Instantly...
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio of strate...